Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 21, pp. 6411-6420
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
Tim Sauer, Kathan Parikh, Sandhya Sharma, et al.
Blood (2021) Vol. 138, Iss. 4, pp. 318-330
Open Access | Times Cited: 148
The CD70-CD27 axis in oncology: the new kids on the block
Tal Flieswasser, Astrid Van den Eynde, Jonas R.M. Van Audenaerde, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 107
An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages
Seyedeh Zahra Bahojb Mahdavi, Fatemeh Oroojalian, Shirin Eyvazi, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 421-442
Closed Access | Times Cited: 70
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Sumanta K. Pal, Ben Tran, John B.A.G. Haanen, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1176-1189
Open Access | Times Cited: 33
ImmunoPET/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study
Qianyun Wu, Yanfei Wu, You Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 8, pp. 2444-2457
Closed Access | Times Cited: 18
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
Angelika M. Starzer, Anna S. Berghoff
ESMO Open (2019) Vol. 4, pp. e000629-e000629
Open Access | Times Cited: 134
Pancreatic Cancer and Immunotherapy: A Clinical Overview
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4138-4138
Open Access | Times Cited: 95
T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
Karin H. Simons, Alwin de Jong, J. Wouter Jukema, et al.
Nature Reviews Cardiology (2019) Vol. 16, Iss. 6, pp. 325-343
Closed Access | Times Cited: 78
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Mathieu Seyfrid, William Maich, Muhammad Vaseem Shaikh, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003289-e003289
Open Access | Times Cited: 51
Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia
Gongqiang Wu, Shanshan Guo, Qian Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy
Thomas Pabst, Norbert Vey, Lionel Adès, et al.
Haematologica (2023) Vol. 108, Iss. 7, pp. 1793-1802
Open Access | Times Cited: 22
Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets
Carlos Cuesta‐Mateos, Ana Alcaraz‐Serna, Beatriz Somovilla-Crespo, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 51
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel, et al.
OncoImmunology (2018) Vol. 7, Iss. 7, pp. e1440167-e1440167
Open Access | Times Cited: 48
SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
Patricia Balsas, Luis Veloza, Guillem Clot, et al.
Blood (2021) Vol. 138, Iss. 22, pp. 2202-2215
Open Access | Times Cited: 34
Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
Jonatan Dewulf, Tal Flieswasser, Tim Delahaye, et al.
EJNMMI Radiopharmacy and Chemistry (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 14
Tumor necrosis factor superfamily signaling: life and death in cancer
Obada Ababneh, Daisuke Nishizaki, Shumei Kato, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1137-1163
Open Access | Times Cited: 5
Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics
Xiaoyan Li, You Zhang, Jason C. Mixdorf, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268835-jnumed.124.268835
Closed Access
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Ji‐Yoon Noh, Huiyun Seo, Jungwoon Lee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8000-8000
Open Access | Times Cited: 32
Update of early phase clinical trials in cancer immunotherapy
Dae Ho Lee
BMB Reports (2021) Vol. 54, Iss. 1, pp. 70-88
Open Access | Times Cited: 29
Immunotherapies targeting stimulatory pathways and beyond
Julian A. Marin‐Acevedo, ErinMarie O. Kimbrough, Rami Manochakian, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer
Sandra Ortiz-Cuarán, Aurélie Swalduz, Jean‐Philippe Foy, et al.
European Journal of Cancer (2022) Vol. 169, pp. 106-122
Open Access | Times Cited: 20
A mechanistic, functional, and clinical perspective on targeting CD70 in cancer
Sandeep Kumar, Sowdhamini Mahendiran, Rakesh Sathish Nair, et al.
Cancer Letters (2024) Vol. 611, pp. 217428-217428
Open Access | Times Cited: 4
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method
Tal Flieswasser, Valérie Camara‐Clayette, Alina Danu, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1611-1611
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top